From GlobeNewswire: 2024-07-26 05:07:00

The U.S. Hemophilia Treatment Market was valued at US$ 4.21 Billion in 2023 and is expected to reach US$ 6.81 Billion by 2031, with a CAGR of 6.2% during 2024-2031. Rising diagnosis rates of hemophilia contribute to the market’s growth, with advancements in screening and diagnostic testing enabling early and accurate diagnosis at birth.

Market dynamics are driven by rising awareness of treatment options and new product launches. Extended half-life therapies requiring fewer injections improve treatment compliance and drive market growth. Hemophilia patient advocacy efforts and strategic collaborations by market leaders contribute to advancements in treatment options.

Key takeaways reveal that the U.S. hemophilia treatment market is poised for a 6.2% CAGR during 2024-2031. Plasma-derived coagulation factors dominated in 2023, with hemophilia A segment accounting for 80% due to high prevalence. Hospital pharmacies remain the dominant distribution channel, with the U.S. leading in market share and key players driving innovation in therapies.

Major players in the U.S. hemophilia treatment market include Takeda Pharmaceutical Company, Sanofi, Octapharma AG, Pfizer Inc., and CSL Behring. Rising adoption of extended half-life factor therapies and ongoing gene therapy trials are driving market trends. Recent developments include FDA approvals for new therapies and positive results from gene therapy studies.

Opportunities in the market include the development of recombinant coagulation factor therapies with extended half-life and reduced immunogenicity. Hospital pharmacies hold the largest market share, but growth opportunities exist in other distribution channels. Market segmentation includes product types, disease types, distribution channels, and geographical regions.

The U.S. Hemophilia Treatment Market is projected to grow at a CAGR of 6.2% by 2031, with revenue forecast, competitive landscape, and growth trends covered in the CoherentMI report. Key questions addressed include factors hindering market growth, leading components, key players, and regional market projections. Other trending reports by CoherentMI cover the United States Pharmaceuticals Market and global healthcare trends.



Read more at GlobeNewswire: U.S. Hemophilia Treatment Market Size to Worth US$ 6.81